(Q84748387)

English

Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3

scientific article published on 10 August 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

based on heuristic

inferred from title

Johannes Pieter Albert Baak

10

object named as

Jan P A Baak

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Emiel A M Janssen

9

object named as

Emiel A M Janssen

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Einar G Gudlaugsson

4

object named as

Einar Gudlaugsson

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Feja J Voorhorst

8

object named as

Feja Voorhorst

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Ane Cecilie Munk

5

object named as

Ane Cecilie Munk

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Irene T Ovestad

1

object named as

Irene T Ovestad

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

6

object named as

Anais Malpica

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

Undis Vennestrøm

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Liv Andersen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Weiwei Feng

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

publication date

10 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

123

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

278-283

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

The natural history of human papillomavirus infection and cervical intraepithelial neoplasia among young women in the Guanacaste cohort shortly after initiation of sexual life.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Papillomavirus infections and human genital cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

How to evaluate emerging technologies in cervical cancer screening?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

The framework of pathology: good laboratory practice by quantitative and molecular methods

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Pilot study of a commercialized human papillomavirus (HPV) genotyping assay: comparison of HPV risk group to cytology and histology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Human papillomavirus oncogenic expression in the dysplastic portio; an investigation of biopsies from 190 cervical cones

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2-3

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Analytical characterization of the APTIMA HPV Assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Management of women who test positive for high-risk types of human papillomavirus: the HART study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Cervical intraepithelial neoplasia grade 3 lesions can regress

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

New approaches to cervical cancer screening in Latin America and the Caribbean

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Cervical cancer screening programs in Latin America and the Caribbean.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.07.024

7 January 2021

Identifiers

10.1016/J.YGYNO.2011.07.024

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21835440%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84748387&oldid=2039597642"